Pump vs control sites had greater vessel density, fibrosis, fibrinogen, and inflammation including eosinophils, insulin-like-growth factor-1 (IGF-1), and transforming growth factor (TGF) β-3, as well ...

NEW YORK (Reuters Health) - Many children and teens using insulin pumps to control type 1 diabetes experience skin problems at the infusion catheter insertion site, but few report thinking about ...

Researchers at the University of Washington School of Medicine recently published a first-of-its-kind study looking at an oft-overlooked problem facing people with diabetes who use insulin pump ...

Skin reactions at insulin pump infusion sites are common among people with type 1 diabetes who use the devices and can lead to delivery failure, new research suggests. Insulin pump use is increasingly ...